Ezt az oldalt automatikusan lefordították, és a fordítás pontossága nem garantált. Kérjük, olvassa el a angol verzió forrásszöveghez.

Personalized and Scalable Cognitive Remediation Approaches

2026. június 19. frissítette: Alice Medalia, New York State Psychiatric Institute
The purpose of this study is to develop and pilot test personalized and scalable approaches to Cognitive Remediation (CR) for schizophrenia and schizoaffective disorder. The intent is to more clearly define the therapeutic targets important to the facilitation of cognitive and functional improvement so that clinicians know how to customize cognitive interventions and deliver treatment in a more effective, efficient and personally relevant manner.

A tanulmány áttekintése

Állapot

Befejezve

Részletes leírás

There are three phases of this study.

Phase 1: Development and Adaptation. The goal of this phase is to adapt currently used computer based CR approaches to make them more personalized and scalable. We will create two CR interventions which differ in choice and pacing of the cognitive exercises. This phase is complete.

Phase 2: Open Trial and Intervention Refinement. The goal of this phase is to obtain quantitative and qualitative feedback on the acceptability and usability of the interventions from participants to inform further refinement of the assessment and treatment packages. We will recruit ten subjects from an outpatient psychiatric rehabilitation program in New York City. After determining study eligibility, individuals will complete a standardized neuropsychological battery for schizophrenia assessment, and a 5-minute Tone Matching Test to assess basic auditory processing. Participants will be randomly assigned to receive one of two intervention packages, developed in Phase 1. Each session includes 60 minutes of computer-based learning activities and a 15 minute therapist-led discussion that links the computer activities to cognition as applied to daily tasks and recovery goals. Participants will complete a total of 10 sessions attending 2-3 times weekly for 5 weeks. During each session, participants will be asked to keep a log of software used. At the conclusion of this abbreviated trial, the participants will participate in focus groups in which they will be asked to provide verbal feedback on how enjoyable, engaging, and useful they perceived the computer and discussion based exercises to be. Participants will be asked to provide verbal feedback on the assessment procedures. CR clinicians will join the research team to discuss participants' engagement and their experience with administering the Tone Matching Test and interventions. Qualitative data summarized from participant logs and focus groups will be considered by the research team to refine the assessment battery, treatment parameters, and rubric of learning exercises. This phase is complete.

Phase 3: Pilot Feasibility Trial. People with a diagnosis of schizophrenia or schizoaffective disorder may be referred by their treating clinician or may respond to posted advertisements to inquire about study participation. After being informed of study procedures, interested individuals will be asked to sign a consent form that documents willingness to participate in this study. Following informed consent, participants will be asked questions about demographic characteristics (e.g. age, education, employment), medication and psychosocial treatment status, psychiatric symptoms and symptoms severity, and will complete a brief assessment of estimated Intelligence. Those with an Intelligence Quotient (IQ) estimate below 70 or meeting substance dependence criteria at the time of evaluation will be exited from the study. In the same or second assessment session, participants will complete assessments of neuropsychological ability, current functioning, and motivation for treatment. Participants will then be randomly assigned to one of two treatment conditions named "Brain Basics" or "Brain Exercises".

Each treatment condition is structured in a group format of up to 5 participants. Both treatments use commercially available computer-based training software to exercise cognitive skills such as speed of processing, attention, working memory, and verbal memory. Both conditions will entail 50 minutes on the computer and 10 minutes group discussion. In the discussion, participants review the cognitive activities they are working on and how they will help them achieve their recovery goals. The treatment phase will consist of 30 separate sessions each 60 minutes in duration, administered 3 times a week over the course of a 10-week period. Participants will be re-tested on outcome measures approximately 1 week following end of treatment, and again 3 months later.

Tanulmány típusa

Beavatkozó

Beiratkozás (Tényleges)

115

Fázis

  • Nem alkalmazható

Kapcsolatok és helyek

Ez a rész a vizsgálatot végzők elérhetőségeit, valamint a vizsgálat lefolytatásának helyére vonatkozó információkat tartalmazza.

Tanulmányi helyek

    • New York
      • Brooklyn, New York, Egyesült Államok, 11206
        • Williamsburg Clinic
      • Brooklyn, New York, Egyesült Államok, 11207
        • Institute for Community Living
      • New York, New York, Egyesült Államok, 10032
        • Nyspi/ Cumc
      • New York, New York, Egyesült Államok, 10040
        • The Bridge Inc
      • The Bronx, New York, Egyesült Államok, 10467
        • FEGS Bronx Mental Health Clinic

Részvételi kritériumok

A kutatók olyan embereket keresnek, akik megfelelnek egy bizonyos leírásnak, az úgynevezett jogosultsági kritériumoknak. Néhány példa ezekre a kritériumokra a személy általános egészségi állapota vagy a korábbi kezelések.

Jogosultsági kritériumok

Tanulmányozható életkorok

18 év (Felnőtt, Idősebb felnőtt)

Egészséges önkénteseket fogad

Nem

Leírás

Inclusion Criteria:

  1. Diagnostic and Statistical Manual-IV (DSM-IV) diagnosis of schizophrenia or schizoaffective disorder
  2. Age 18 to 65
  3. English speaking
  4. Psychiatrically stable, verified by current living/treatment status

Exclusion Criteria:

  1. Indication of mental retardation, determined by estimated IQ of less than 70
  2. Hearing or visual impairment that precludes completing assessments
  3. Neurologic illness that may affect brain physiology (e.g. Parkinson's, seizure disorder, epilepsy)
  4. Current substance dependence symptoms in the past 6 weeks
  5. Participation in cognitive remediation in the 12 months prior to study entry.

Tanulási terv

Ez a rész a vizsgálati terv részleteit tartalmazza, beleértve a vizsgálat megtervezését és a vizsgálat mérését.

Hogyan készül a tanulmány?

Tervezési részletek

  • Elsődleges cél: Kezelés
  • Kiosztás: Véletlenszerűsített
  • Beavatkozó modell: Párhuzamos hozzárendelés
  • Maszkolás: Egyetlen

Fegyverek és beavatkozások

Résztvevő csoport / kar
Beavatkozás / kezelés
Aktív összehasonlító: Brain Basics for Impaired Tone Matchers
Cognitive remediation includes sensory processing training
Cognitive remediation sessions include working on computer based cognitive exercises and participating in a verbal discussion.
Aktív összehasonlító: Brain Basics for Intact Tone Matchers
Cognitive remediation includes sensory processing training
Cognitive remediation sessions include working on computer based cognitive exercises and participating in a verbal discussion.
Aktív összehasonlító: Brain Training for Impaired Tone Matcher
Cognitive remediation does not include sensory processing training
Cognitive remediation sessions include working on computer based cognitive exercises and participating in a verbal discussion.
Aktív összehasonlító: Brain Training for Intact Tone Matchers
Cognitive remediation does not include sensory processing training
Cognitive remediation sessions include working on computer based cognitive exercises and participating in a verbal discussion.

Mit mér a tanulmány?

Elsődleges eredményintézkedések

Eredménymérő
Intézkedés leírása
Időkeret
Feasibility of Enrollment, Randomization and Retention
Időkeret: Two years
Feasibility is measured by enrollment, acceptability of randomization defined as number initiated allocated treatment, retention of subjects defined as number completed allocated treatment
Two years

Másodlagos eredményintézkedések

Eredménymérő
Intézkedés leírása
Időkeret
Change in Neurocognition From Baseline to Treatment End-point
Időkeret: 10 weeks
Change in neurocognition is calculated as the difference in the MATRICS Consensus Cognitive Battery Neurocognitive Composite Score between baseline and treatment end-point (10 weeks). The MATRICS Consensus Cognitive Battery Neurocognitive Composite T-Score is a scaled score calculated from the following component subscales: a) working memory; b) attention/vigilance; c) verbal learning; d) visual learning; e) processing speed; f) reasoning and problem solving. The mean T-score is 50 with a standard deviation of 10. Higher scores on the scale mean better outcomes. Higher change scores mean better outcomes.
10 weeks
Change in Neurocognition From Baseline to 3-month Follow-up
Időkeret: 5.5 to 6 months
Change in neurocognition is calculated as the difference in the MATRICS Consensus Cognitive Battery Neurocognitive Composite Score between baseline and 3-month follow-up (5.5 to 6 months). The MATRICS Consensus Cognitive Battery Neurocognitive Composite T-Score is a scaled score calculated from the following component subscales: a) working memory; b) attention/vigilance; c) verbal learning; d) visual learning; e) processing speed; f) reasoning and problem solving. The mean T-score is 50 with a standard deviation of 10. Higher scores on the scale mean better outcomes. Higher change scores mean better outcomes.
5.5 to 6 months

Egyéb eredményintézkedések

Eredménymérő
Intézkedés leírása
Időkeret
Intrinsic Motivation Inventory for Schizophrenia Research (IMI-SR)
Időkeret: 10 weeks
Intrinsic Motivation Inventory for Schizophrenia Research (IMI-SR), a 21 item 7-point Likert type scale designed to assess a participant's subjective experience of an activity, specifically in an experimental setting (e.g. "I enjoyed doing this activity very much"). The IMI-SR will be administered at the first and last treatment sessions.
10 weeks
Perceived Competency Scale (PCS)
Időkeret: 10 weeks
The PCS consists of 4 items on a 7-point Likert-type scale that assess feelings of competency when performing computer-based learning activities, with higher scores indicating greater perceived competency. The PCS will be administered at the first and last treatment sessions.
10 weeks
Change in Tone Matching Ability From Baseline to Treatment End-point
Időkeret: 10 weeks
Change in Tone Matching (percent correct) will be calculated as the difference between scores measured at baseline and treatment end-point (10 weeks), using pairs of 100-ms tones in series, with 500-ms inter-tone interval. The values on this scale range from 0% to 100% where higher scores mean better outcomes. Higher change scores mean better outcomes.
10 weeks
Change in UCSD Performance-Based Skills Assessment (UPSA)-Brief From Baseline to Treatment End-point
Időkeret: 10 weeks
The UPSA - Brief is a proxy measure of daily functioning skills. Change from baseline to treatment end-point (10 weeks) will be assessed as the difference between the two scores. The scale score can range from 0 to 100. Higher scores mean better outcomes. Higher change scores mean better outcomes.
10 weeks
Structured Clinical Interview for the Positive and Negative Syndrome Scale (SCI-PANSS) - Treatment End-point
Időkeret: 10 weeks
The SCI-PANSS is a semi-structured interview containing 30 items that assess symptoms of psychotic disorders including positive, negative and general psychopathology. Change from baseline to treatment end-point (10 weeks) will be assessed. Higher scores mean higher symptom severity. Change is calculated as the difference between the two scores. Greater change scores mean greater symptom improvement.
10 weeks
Change in Tone Matching Ability From Baseline to 3-month Follow up
Időkeret: 5.5 to 6 months
Change in Tone Matching (percent correct) will be calculated as the difference in scores assessed at baseline and 3-month follow-up (5.5 to 6 months), using pairs of 100-ms tones in series, with 500-ms inter-tone interval. The values on this scale range from 0% to 100% where higher scores mean better outcomes. Greater change scores mean greater improvement.
5.5 to 6 months
Change in UCSD Performance-Based Skills Assessment (UPSA)-Brief From Baseline to 3-month Follow-up
Időkeret: 5.5 to 6 months
The UPSA-Brief is a proxy measure for daily functioning skills. The scale score ranges from 0-100. Change from baseline to 3-month follow-up (5.5-6 months) will be assessed as the difference between the two scores. Higher scores mean better outcomes. Higher change scores mean better outcomes.
5.5 to 6 months
Structured Clinical Interview for the Positive and Negative Syndrome Scale (SCI-PANSS) - 3-month Follow-up
Időkeret: 5.5 to 6 months
The SCI-PANSS is a semi-structured interview containing 30 items that assess symptoms of psychotic disorders including positive, negative and general psychopathology. Change from baseline to 3-month follow-up will be assessed.
5.5 to 6 months

Együttműködők és nyomozók

Itt találhatja meg a tanulmányban érintett személyeket és szervezeteket.

Nyomozók

  • Kutatásvezető: Alice Medalia, PhD, NYSPI

Publikációk és hasznos linkek

A vizsgálattal kapcsolatos információk beviteléért felelős személy önkéntesen bocsátja rendelkezésre ezeket a kiadványokat. Ezek bármiről szólhatnak, ami a tanulmányhoz kapcsolódik.

Tanulmányi rekorddátumok

Ezek a dátumok nyomon követik a ClinicalTrials.gov webhelyre benyújtott vizsgálati rekordok és összefoglaló eredmények benyújtásának folyamatát. A vizsgálati feljegyzéseket és a jelentett eredményeket a Nemzeti Orvostudományi Könyvtár (NLM) felülvizsgálja, hogy megbizonyosodjon arról, hogy megfelelnek-e az adott minőség-ellenőrzési szabványoknak, mielőtt közzéteszik őket a nyilvános weboldalon.

Tanulmány főbb dátumok

Tanulmány kezdete

2013. szeptember 1.

Elsődleges befejezés (Tényleges)

2017. október 2.

A tanulmány befejezése (Tényleges)

2019. március 20.

Tanulmányi regisztráció dátumai

Először benyújtva

2013. szeptember 13.

Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak

2013. szeptember 13.

Első közzététel (Becsült)

2013. szeptember 18.

Tanulmányi rekordok frissítései

Utolsó frissítés közzétéve (Tényleges)

2026. július 17.

Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak

2026. június 19.

Utolsó ellenőrzés

2026. június 1.

Több információ

A tanulmányhoz kapcsolódó kifejezések

Terv az egyéni résztvevői adatokhoz (IPD)

Tervezi megosztani az egyéni résztvevői adatokat (IPD)?

NEM

IPD terv leírása

This trial started enrolling participants before January 1, 2019.

Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .

Iratkozz fel